Tag: Marcos Agramont

Isodiol International Inc. Appoints Board Member

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”) is pleased to announce the appointment of Mr. Leonardo Matesanz to its...

Isodiol International Inc. Provides Update on Mexico Operations and US Farm Bill

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), would like to update shareholders on its operations in Mexico. On October 30,...

Isodiol International Inc. Announces Appointment of Franco Columbu to Iso-Sport Management Team

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), is pleased to announce that actor, author, former champion bodybuilder and World's Strongest...

Isodiol International Inc. Announces CBD Beverage Expansion Plans Through Florida Based Subsidiary, IsoBev

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), is providing an update on its recently acquired Florida based bottler, Azure. 

ISO-SPORT™ Products Now Available Through Two UK-based Mixed Martial Arts Companies

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F)(the “Company” or “Isodiol”) is pleased to announce that its subsidiary, ISO-SPORT™, has reached deals with two United Kingdom-based mixed...

Isodiol International Inc. Subsidiary, BSPG Laboratories LTD., Launches API Sales and Marketing Program at CPhI 2018

BSPG Laboratories introduces cannabidiol (CBD) API to over 45,000 pharmaceutical industry professionals from over 150 countries at the world’s largest...

Isodiol International Inc. Appoints Patrick Ogle as Chief Operating Officer and as a member of its Board of Directors; Appoints Dr. David Putrino, Ph.D., to Medical Advisory Board

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company”)  announces that its general counsel for M&A, Corporate and Securities, Patrick Ogle has been appointed as...